A1C vs Time in Range: Which Is Better for Diabetes Control?

A1C vs Time in Range: Which Is Better for Diabetes Control?

A1C vs Time in Range compares two useful but very different ways of measuring diabetes control. A1C provides a longer-term average, while Time in Range shows what your glucose is doing throughout the day.

Quick Answer: A1C vs Time in Range

Neither A1C nor Time in Range (TIR) is universally better. A1C reflects average glucose exposure over roughly two to three months, while Time in Range shows the percentage of time your glucose stays within a target range. For people using a continuous glucose monitor (CGM), looking at both can provide a more complete picture of glucose control. 1

Key Takeaways

  • A1C reflects average glucose exposure over approximately two to three months.
  • Time in Range shows how much time CGM glucose readings stay within a defined target range.
  • For many nonpregnant adults with diabetes, a common TIR goal is more than 70% between 70 and 180 mg/dL.1
  • Two people can have similar A1C results but very different patterns of highs and lows.
  • A1C and TIR generally work best together rather than as replacements for each other.

A1C vs Time in Range at a Glance

A1CTime in Range
What it measuresAverage glucose exposurePercentage of CGM readings within target
Typical periodAbout 2–3 monthsRecent CGM data
Requires a CGMNoYes
Shows highs and lowsNoYes
Used for diabetes diagnosisYesNo
Shows daily glucose patternsLimitedYes

What A1C Shows

A1C measures the percentage of hemoglobin in red blood cells that has glucose attached to it. Because red blood cells circulate for months, the test provides an overall picture of recent glucose exposure.

For many nonpregnant adults with diabetes, the American Diabetes Association (ADA) recommends an A1C goal of less than 7%, although individual targets can be higher or lower depending on health, hypoglycemia risk, treatment burden and other factors.1

If you’re unsure what your result means, see our guide to understanding A1C.

A1C is useful, but it has one important limitation: an average cannot show when glucose was high, low or rapidly changing.

If you want to convert an A1C result into estimated average glucose, use the A1C Calculator.

What TIR Shows Day to Day

Time in Range measures the percentage of time CGM glucose readings fall within a specified target range.

For many adults with type 1 or type 2 diabetes, the standard range is:

70–180 mg/dL (3.9–10.0 mmol/L).

The ADA recommends a goal of more than 70% Time in Range for many nonpregnant adults using CGM.1

Seventy percent of a day equals about 16 hours and 48 minutes within range.

Unlike A1C, CGM data can show how much time you spend in, above, and below your target glucose range.2

  • Above 180 mg/dL
  • Above 250 mg/dL
  • Below 70 mg/dL
  • Below 54 mg/dL

That additional information can reveal glucose patterns that an average A1C cannot.3

Why A1C Can Look Good When Time in Range Does Not

One of the biggest differences between A1C and TIR is that the same average can come from very different glucose patterns.

Consider two hypothetical people:

Person APerson B
A1CSimilarSimilar
Glucose patternRelatively stableFrequent highs and lows
Time in RangeHigherLower

Their average glucose exposure may be similar, but their daily experiences are very different.

A1C alone cannot identify how much time someone spends in hypoglycemia or hyperglycemia. Time in Range, Time Below Range and Time Above Range help fill that gap.3

Does 70% Time in Range Equal a 7% A1C?

Approximately—but not exactly.

Research used in current clinical guidance has found that a TIR above 70% often corresponds roughly to an A1C around 7%.1

However, TIR should not be treated as a direct A1C conversion formula.

Studies have found substantial variation between individuals. In the international consensus analysis, a 70% TIR corresponded to an estimated A1C of about 7% in one dataset, but the range around that estimate was wide.3

That means two people with 70% TIR will not necessarily have identical A1C results.

Why Your A1C and CGM Results May Not Match

It’s also possible for laboratory A1C and CGM-derived measurements to tell somewhat different stories.

Reasons can include:

  • Recent changes in glucose control
  • Differences in red blood cell lifespan
  • Anemia or certain other medical conditions
  • The amount of CGM data available
  • Normal biological differences between people

CGM reports may also show a Glucose Management Indicator (GMI). GMI estimates an A1C-like value from average CGM glucose, but it is not the same as a laboratory A1C.1

For a deeper look at this issue, see why A1C and glucose readings may not match.

What I’ve Learned From Using Both

After years of managing diabetes, I find A1C useful for seeing the bigger picture, but CGM data adds context that an average simply cannot provide.

Time in Range lets me see how glucose behaves throughout the day—after meals, during exercise and at other times when patterns can be easy to miss. It also makes it easier to see whether changes are moving glucose in the right direction before the next A1C test.

For me, the most useful approach is not choosing one number over the other. A1C shows the longer-term picture, while Time in Range helps fill in the details.

Is Time in Range Better Than A1C?

For day-to-day diabetes management, Time in Range can be more actionable because it shows when glucose is within, above or below the target range.

But that does not make A1C obsolete.

A1C remains an established laboratory measurement used for diagnosing diabetes and assessing longer-term glucose exposure. TIR provides additional information about daily glucose patterns, hyperglycemia and hypoglycemia.

The 2026 ADA Standards recognize both A1C and CGM metrics such as TIR when assessing glycemic status.1

For people who use CGM, the better question is therefore not A1C or Time in Range.

It’s what are they telling you together?

What Time in Range Should You Aim For?

For many nonpregnant adults with type 1 or type 2 diabetes, commonly recommended CGM targets include:1

CGM MetricCommon Goal
Time 70–180 mg/dL>70%
Time above 180 mg/dL<25%
Time above 250 mg/dL<5%
Time below 70 mg/dL<4%
Time below 54 mg/dL<1%

These goals are not appropriate for everyone. Targets may differ for older adults, people at high risk of hypoglycemia, pregnancy and other individual circumstances.

Your diabetes care team can help determine targets that are appropriate for you.

Why Both Metrics Matter

A1C vs Time in Range is best understood as a comparison of two metrics that answer different questions.

A1C asks: What has my average glucose exposure looked like over the past few months?

Time in Range asks: How much of my time am I actually spending within my glucose target?

A1C provides the long-term view. TIR shows the daily details.

For people using CGM, using both can provide a more complete picture of diabetes control than relying on either number alone.

Frequently Asked Questions About A1C vs Time in Range

For many nonpregnant adults with type 1 or type 2 diabetes, a common goal is to spend more than 70% of the time between 70 and 180 mg/dL.1 Targets should be individualized.

Not exactly. Research shows that 70% TIR often corresponds approximately to an A1C around 7%, but there can be substantial individual variation.3

Yes. Frequent highs and lows can average out to an acceptable A1C. TIR and related CGM metrics can reveal glucose variability that A1C alone cannot show.

No. TIR complements A1C rather than replacing it. A1C remains useful for longer-term assessment and diagnosis, while TIR provides more detail about everyday glucose patterns.

For pattern management, current ADA guidance recommends at least 14 days of CGM wear with about 70% of the data available.1

Medically reviewed by Dr. Seshadri G. Das, MD
Board Certified in Endocrinology, Diabetes & Metabolism
Last updated: October 2026

References

  1. American Diabetes Association Professional Practice Committee. “6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes—2026.” Diabetes Care. 2026;49(Supplement 1)–S149. [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩] [↩]
  2. American Diabetes Association. “CGM & Time in Range.” American Diabetes Association. [↩]
  3. Battelino T, Danne T, Bergenstal RM, et al. “Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range.” Diabetes Care. 2019;42(8):1593–1603. [↩] [↩] [↩] [↩]

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.